Electroencephalography

MicroCloud Hologram (NASDAQ: HOLO) Announces the Launch of A Holographic Brain-Computer Interface(BCI) Data Acquisition System

Retrieved on: 
Thursday, January 26, 2023
Human, BCI, Algorithm, DSP, Brain, Robotics, Brain–computer interface, EEG, Electroencephalography, Acquisition, AD, Multimedia, Research, Medical imaging, Computer data storage

BEIJING, Jan. 26, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced the launch of its holographic BCI (Brain-Computer Interface) data acquisition system.

Key Points: 
  • BEIJING, Jan. 26, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced the launch of its holographic BCI (Brain-Computer Interface) data acquisition system.
  • HOLO's holographic BCI data acquisition system combines BCI with holographic technology, enabling the two technologies to complement each other.
  • HOLO's holographic brain computer interface data acquisition system includes EEG amplification holographic data generation part, digital control part and intelligent algorithm part.
  • Eeg amplifier circuit is mainly used to complete the holographic data amplification of EEG, so as to facilitate the subsequent holographic data processing of EEG acquisition system.

Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS

Retrieved on: 
Wednesday, January 18, 2023
Neuro, Electromyography, EEG, Polysomnography, EMG, Sensory, Electroencephalography, ICU, Diagnosis, Growth, Patient, PSG, Acquisition, Risk management, Micromation

MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.  Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.

Key Points: 
  • MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.
  • Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.
  • "We are thrilled to complete this deal and move forward combining the Natus and Micromed teams and product portfolios," said Austin Noll, Natus President and leader of Natus Neuro.
  • "The acquisition of Micromed is the first transaction in our acquisition roadmap to build leading companies in both Neuro and Sensory under the Natus umbrella," said Thomas J. Sullivan, Natus Chief Executive Officer.

Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS

Retrieved on: 
Wednesday, January 18, 2023
Neuro, Electromyography, EEG, Polysomnography, EMG, Sensory, Electroencephalography, ICU, Diagnosis, Growth, Patient, PSG, Acquisition, Risk management, Micromation

MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.  Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.

Key Points: 
  • MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.
  • Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.
  • "We are thrilled to complete this deal and move forward combining the Natus and Micromed teams and product portfolios," said Austin Noll, Natus President and leader of Natus Neuro.
  • "The acquisition of Micromed is the first transaction in our acquisition roadmap to build leading companies in both Neuro and Sensory under the Natus umbrella," said Thomas J. Sullivan, Natus Chief Executive Officer.

Sensus Healthcare Announces Senior Management Appointments and Promotions

Retrieved on: 
Monday, January 9, 2023
Sentinel, Eclipse, Air force, Social media, Research, Information, Santa Clara University, Dermatology, Respect, University, San Jose State University, SCU Leavey School of Business, Business, Concordia University Texas, Quality assurance, Stetson University, Electroencephalography, Physics, Digital marketing, Second lieutenant, National university, Brain, Food and Drug Administration, Concordia University, Kyiv National University of Technologies and Design, Biology, Penn State Air Force ROTC, Marketing, Food, Growth, Moses Austin, Engineering, Patient, University of Buenos Aires, Intelligence, Software, Workforce, BOCA, Industrial, MBA, Regulation, Small business, GPS, Medical imaging, Management, Medical device, Cynosure, SensUs, Operation, EU

BOCA RATON, Fla, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce the following promotions and appointments to its management team:

Key Points: 
  • BOCA RATON, Fla, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce the following promotions and appointments to its management team:
    Ms. Martinez joined Sensus nine years ago and subsequently held positions of increasing responsibility.
  • Mr. Sosa joined Sensus last year as Vice President of Technology Development with extensive experience in banking, cyber security and artificial intelligence.
  • I am delighted to announce these promotions and appointments and look forward to the contributions of these talented individuals as Sensus executes on an aggressive business strategy,” said Joe Sardano, chairman and chief executive officer of Sensus Healthcare.
  • “Our goal is for Sensus to be a destination for great employees from all walks of life and backgrounds.

Brain Mapping Instruments Market to Witness CAGR of 13% (2022-2028) on account of Increasing Prevalence of Neurodegenerative Disorders | UnivDatos Market Insights

Retrieved on: 
Tuesday, December 6, 2022
Neuroimaging, Hospital, Neurological disorder, Medtronic, Brain mapping, Transport, PET, Diagnosis, Stroke, Prevalence, Sleep, CAT, Epilepsy, Magnetoencephalography, Magnetic resonance, Infrared spectroscopy, EGG, World Health Organization, Electroencephalography, COVID-19, Behavior, Midsayap Diagnostic Center and Hospital, Growth, EEG, WHO, Brain, Magnetic resonance imaging, Social isolation, Multiple sclerosis, Seizure, CDC, USD, Medical imaging, NOIDA

This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.

Key Points: 
  • This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.
  • Furthermore, this statistical market research repository examines and estimates the brain mapping instruments market at the global and regional levels.
  • Furthermore, the rising prevalence of brain disorders coupled with the increasing efforts to understand the brain complexities for future disease treatment catalyzing the market growth of brain mapping instruments.
  • Brain Mapping Instruments Market Geographical Segmentation Includes:
    North America constitutes a significant brain mapping instruments market due to the increasing R&D activities and frequent product launches in the region.

Brain Mapping Instruments Market to Witness CAGR of 13% (2022-2028) on account of Increasing Prevalence of Neurodegenerative Disorders | UnivDatos Market Insights

Retrieved on: 
Tuesday, December 6, 2022
Neuroimaging, Hospital, Neurological disorder, Medtronic, Brain mapping, Transport, PET, Diagnosis, Stroke, Prevalence, Sleep, CAT, Epilepsy, Magnetoencephalography, Magnetic resonance, Infrared spectroscopy, EGG, World Health Organization, Electroencephalography, COVID-19, Behavior, Midsayap Diagnostic Center and Hospital, Growth, EEG, WHO, Brain, Magnetic resonance imaging, Social isolation, Multiple sclerosis, Seizure, CDC, USD, Medical imaging, NOIDA

This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.

Key Points: 
  • This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.
  • Furthermore, this statistical market research repository examines and estimates the brain mapping instruments market at the global and regional levels.
  • Furthermore, the rising prevalence of brain disorders coupled with the increasing efforts to understand the brain complexities for future disease treatment catalyzing the market growth of brain mapping instruments.
  • Brain Mapping Instruments Market Geographical Segmentation Includes:
    North America constitutes a significant brain mapping instruments market due to the increasing R&D activities and frequent product launches in the region.

Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022

Retrieved on: 
Monday, December 5, 2022
Seoul National University Bundang Hospital, Drowning, Seizure, Epilepsy, Accident, Ageing, AES, SK, American Epilepsy Society, Central nervous system, Neurological disorder, Falling, Patient, SUDEP, Research, Central nervous system disease, Death, Brain, World Health Organization, Electroencephalography, Epilepsy Foundation, Multimedia, EEG, Safety, Work, Depression, CNS, Risk, Pharmaceutical industry, Medical device

PANGYO, South Korea, Dec. 4, 2022 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH) presented its preliminary study result of seizure monitoring for patients with epilepsy using SK Biopharmaceuticals' multimodal wearable device at the American Epilepsy Society (AES) Annual Meeting 2022 in Nashville, Tennessee, December 2-6. This is the first study of the wearable device developed by SK Biopharmaceuticals, an innovative global pharmaceutical company.

Key Points: 
  • PANGYO, South Korea, Dec. 4, 2022 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH) presented its preliminary study result of seizure monitoring for patients with epilepsy using SK Biopharmaceuticals' multimodal wearable device at the American Epilepsy Society (AES) Annual Meeting 2022 in Nashville, Tennessee, December 2-6.
  • This is the first study of the wearable device developed by SK Biopharmaceuticals, an innovative global pharmaceutical company.
  • SK Biopharmaceuticals and SNUBH plan to further pursue clinical research with Zero WiredTM, aiming to develop it into an AI-based seizure detection and forecast device.
  • Zero Wired, a CES 2023 Innovation Awards Honoree, is an upgraded version of the multimodal wearable device used in the SNUBH pilot study.

Zeto Implements encevis' Seizure Detection and Trending Algorithms

Retrieved on: 
Thursday, December 1, 2022
Software, Deep learning, Electroencephalography, AI, AIT, Hospital, Physician, Patient, Neurological disorder, Seizure, EEG, National Association Medical Staff Services, Research, FDA, Algorithm, Medical imaging, Zeto

SANTA CLARA, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , an innovative EEG brain monitoring company, announced today the integration of FDA cleared seizure detection and trending algorithms developed by encevis , now available as part of the Zeto EEG platform.

Key Points: 
  • SANTA CLARA, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , an innovative EEG brain monitoring company, announced today the integration of FDA cleared seizure detection and trending algorithms developed by encevis , now available as part of the Zeto EEG platform.
  • The trending module graphically reports several hours of EEG into a simple display to allow rapid assessment of brain states.
  • The seizure detection component offers high sensitivity with low false alarm rates, matching and in parts surpassing industry benchmarks.
  • "We are excited to integrate encevis' seizure detection and trending tools into our platform.

Medical Electrodes Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Wednesday, November 30, 2022
COVID-19, Neurophysiology, Electrode, Diagnosis, Cardiology, EMG, Thermo Fisher Scientific, Electroencephalography, Medtronic, Electrocardiography, Organization, Electromyography, Ethicon Inc., GE Healthcare, Cardinal Health, Lead, Boston Scientific, Electricity, Percussion section, Sleep, 3M, Acquisition, Medical device, Electric battery

The main usability of medical electrodes is disposable medical electrodes and reusable medical electrodes.Disposable medical electrodes refer to the disposable medical electrode consisting of a disc made of a semi-rigid plastic substance with a centrally positioned recessed embossment.

Key Points: 
  • The main usability of medical electrodes is disposable medical electrodes and reusable medical electrodes.Disposable medical electrodes refer to the disposable medical electrode consisting of a disc made of a semi-rigid plastic substance with a centrally positioned recessed embossment.
  • The market is witnessing the demand for prominent electrodes such as electrocardiography electrodes, electroencephalography electrodes, and others.Major companies operating in the medical electrodes market are advancing new technologies and advanced medical electrodes products to strengthen their market position.
  • The market is witnessing the demand for prominent electrodes such as electrocardiography electrodes, electroencephalography electrodes, and others.Major companies operating in the medical electrodes market are advancing new technologies and advanced medical electrodes products to strengthen their market position.
  • The medical electrodes market research report is one of a series of new reports that provides medical electrodes market statistics, including medical electrodes industry global market size, regional shares, competitors with an medical electrodes market share, detailed medical electrodes market segments, market trends and opportunities, and any further data you may need to thrive in the medical electrodes industry.

The Global Medical Electrodes Market size is expected to reach $2 Billion by 2028, rising at a market growth of 3.8% CAGR during the forecast period

Retrieved on: 
Monday, November 28, 2022
Neurophysiology, Neurological disorder, Heart, ECG, Skin, Scalp, TENS, BCIS, Electrode, Diagnosis, EMG, Electroencephalography, Degenerative disease, Electromyography, Prevalence, Lead, Brain, Medtronic, Patient, IOM, Electrocardiography, Aarhus University, Electrosurgery, Electricity, Death, EEG, Metal, CVD, Becton, Dickinson and Company headquarters, Sleep, Carbon, Research, Muscle, The Cooper Companies, 3M, Needle, Medicine, Infarction, Stroke, Cardiology, Medical device, Pharmaceutical industry

View original content:https://www.prnewswire.com/news-releases/the-global-medical-electrodes-m...

Key Points: 
  • NEW YORK, Nov. 28, 2022 /PRNewswire/ -- The Global Medical Electrodes Market size is expected to reach $2 Billion by 2028, rising at a market growth of 3.8% CAGR during the forecast period.
  • In the coming years, the medical electrode market is bound to grow owing to the increased R&D in the field.
  • Based on product type, the medical electrodes market is bifurcated into surface electrodes and needle electrodes.
  • On the basis of application, the medical electrodes market is divided into cardiology, neurophysiology, electrosurgery, interoperative monitoring (IOM), and sleep study.